Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

CANCER BUZZ, the ACCC podcast, has a fresh new look!

The refresh of the CANCER BUZZ logo reflects our commitment to hosting timely, relevant discussions with our multidisciplinary membership. From the front desk to the C-suite, from clinical research to cancer survivorship, and everywhere in between, CANCER BUZZ is the place where oncology leaders and disruptors connect on the most pressing questions and innovations shaping cancer care today.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Filter By Podcast Format

 
 
 
 
 
After 6 years of bringing listeners key insights into the most pressing topics in oncology, ACCC’s podcast, CANCER BUZZ, has gotten a facelift! In this episode, CANCER BUZZ brings back our first podcast guest, Tina Curtis, DNP, MBA, RN, NEA-BC, executive director of cancer services at Froedtert Hospital. In the June 26, 2019, inaugural CANCER BUZZ episode, Dr. Curtis spoke about her …
Una Hopkins, DNP, MSN, FNP-BC, NE-BC, RN, FACCC, president of the Association of Cancer Care Centers (ACCC) designated her theme for the 2025-2026 year as Designing Oncology Care to Meet the Needs of a Growing Patient Population in response to forecasts predicting both patient and survivor populations will grow in coming years. In this episode, CANCER BUZZ speaks with Dr. Hopkins about the importance …
US Veterans are at a heightened risk for lung cancer due to service-related exposures. Integrating clinical research into routine oncology care at the US Department of Veterans Affairs (VA) can help bring clinical trials closer to where Veterans live and improve access to cutting edge therapies. In this episode, CANCER BUZZ speaks with Millie Das, MD, chief of oncology at the VA Palo Alto Health Care …
Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) is an emerging biomarker present in about 38% of patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. In this episode, CANCER BUZZ speaks with Nataliya Uboha, MD, PhD, a medical oncologist at University of Wisconsin Health, about current recommendations for biomarker testing in this population, emerging biomarkers …
In metastatic breast cancer, resistance to therapy remains one of the most challenging aspects to care. A key driver of resistance in hormone receptor-positive, HER2-negative disease is the ESR1 mutation, a genetic change that alters the estrogen receptor and limits the effectiveness of certain standard therapies. In this episode, CANCER BUZZ speaks with Eleonara Teplinsky, MD, FASCO, head of breast …
Live from ACCC’s 42nd National Oncology Conference (NOC), CANCER BUZZ sits down with Dr. Deirdre Saulet to unpack key takeaways from Friday morning’s panel, Women Leaders in Oncology: Exploring Successful Dyad Models.
Live from the NOC: Executive Director on Unleashing Innovation
Part 2 of the 2025 Trending Now in Cancer Care report focuses on payer-driven challenges and solutions, comprehensive cancer care services, research and clinical trials, and mobile screening to engage communities in cancer prevention and education. The full article can be found in Oncology Issues, the official journal of ACCC.
Part 1 of the 2025 Trending Now in Cancer Care report focuses on AI and BI solutions, navigating tech enablement, strategic partnerships and affiliations, and growth opportunities in oncology. The full article can be found in Oncology Issues, the official journal of ACCC.
CANCER BUZZ catches up with attendees of the ACCC 42nd National Oncology Conference (NOC) to discuss key takeaways from this year’s hot topic sessions.
In this episode live from ACCC’s 42nd National Oncology Conference (NOC) in Denver, Dr. Una Hopkins hosts the President’s Fireside Chat, spotlighting three cancer programs that are reimagining care delivery to meet the needs of a growing patient population.
Live this week from ACCC’s 42nd National Oncology Conference (NOC), CANCER BUZZ speaks with ACCC Board of Trustees member Jennifer Bires, who highlights Wednesday’s panel discussion she led, “POPS: Navigating Quality Integrative Cancer Support Resources.”
The George Washington Cancer Center serves a racially, ethnically, and socioeconomically diverse population across Washington, D.C., northern Virginia, and southern Maryland. Their Breast Cancer Program has found that a community-informed model is most successful for managing care and adverse events related to CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Pavani Chalasani, MD, MPH, director …
In this episode, CANCER BUZZ speaks with Scott J. Capozza, PT, MSPT, on his journey navigating care after cancer treatment as a young adult and his ASCO JCO Oncology Practice article, “Patient is Otherwise Healthy.” CANCER BUZZ then speaks with Melody Griffith, MSW, LMSW, Outpatient Adolescent and Young Adult (AYA) Oncology social worker at Mayo Clinic Arizona, on her role in patient navigation …
This podcast, supported by state society oncology programs, discusses different approaches to onboarding, mentorship, and role optimization tailored to each institution’s unique needs and resources. CANCER BUZZ speaks with Jennifer Gray, DNP, ACNP-BC, AOCNP, assistant director of advanced practice at Atrium Health Levine Cancer Institute on her experience onboarding APPs with different experience …
In this episode, CANCER BUZZ speaks with Susan Salgado, PhD, keynote speaker at the upcoming 42nd National Oncology Conference, about her approach to organizational culture and leadership. With over 2 decades of experience in consulting spanning more than 20 industries, Dr. Salgado is adept at transferring hospitality skills to the field of health care. She discusses the importance of zeroing in on …
In this episode, CANCER BUZZ facilities a candid conversation with Glenis Redmond, who received treatment at Gibbs Cancer Center and Research Institute for multiple myeloma, and 2 members of her cancer treatment team: clinical research coordinator Audrianna Carrington and oncologist hematologist Dr. Tondre Buck, about overcoming barriers, ensuring shared decision-making, and improving the inclusion …
In this episode, CANCER BUZZ speaks with Keri Halsema, NP, MSN, RN, nurse practitioner in the Blood Disorders Center at the University of Colorado Anschutz about the factors that influence treatment choices and the use of menin inhibitors to treat relapsed or refractory AML.
The high cost associated with cancer diagnosis, treatment, and survivorship makes the burden of financial toxicity an unavoidable reality for many patients—and makes financial navigators central to the delivery of high-quality cancer care. In this vodcast episode, CANCER BUZZ speaks with Heather Simpson, BCPA, patient financial navigator lead, who shares her experience using the ACCC Financial …
Effective management of adverse events and addressing barriers to care are critical to optimizing outcomes and maintaining quality of life for patients receiving CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Julia Lea Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator in solid tumor oncology at Atrium Health Levine Cancer Institute about proactive, team-based strategies to …
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.